aglycosylated antibodies (BioSavita)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameaglycosylated antibodies (BioSavita)

Drug Alias NameCC49-IL15 immunotherapeutic (BioSavita)therapeutic aglycosylated antibodies (ApoLife)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBiosavita

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBiosavita

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A